Thereafter, the changes in tumor weight and volume were analyzed and the results revealed that NAT10 silencing inhibited in vivo tumor growth, while this tendency was reversed by FOXM1 overexpression (Figure 5b–c). The gene discussed is FOXM1; the disease is neoplasm.